Suppr超能文献

ERK2 而非 ERK1 通过 DEF 基序依赖性信号事件诱导上皮-间充质转化。

ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.

机构信息

Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.

出版信息

Mol Cell. 2010 Apr 9;38(1):114-27. doi: 10.1016/j.molcel.2010.02.020.

Abstract

Hyperactivation of Ras-ERK1/2 signaling is critical to the development of many human malignancies, but little is known regarding the specific contribution of ERK1 or ERK2 to oncogenic processes. We demonstrate that ERK2 but not ERK1 signaling is necessary for Ras-induced epithelial-to-mesenchymal transformation (EMT). Further, ERK2 but not ERK1 overexpression is sufficient to induce EMT. Many ERK1/2-interacting proteins contain amino acid motifs, e.g., DEF or D-motifs, which regulate docking with ERK1/2. Remarkably, ERK2 signaling to DEF motif-containing targets is required to induce EMT and correlates with increased migration, invasion, and survival. Importantly, the late-response gene product Fra1 is necessary for Ras- and ERK2-induced EMT through upregulation of ZEB1/2 proteins. Thus, an apparent critical role for ERK2 DEF motif signaling during tumorigenesis is the regulation of Fra1 and the subsequent induction of ZEB1/2, suggesting a potential therapeutic target for Ras-regulated tumorigenesis.

摘要

Ras-ERK1/2 信号的过度激活对许多人类恶性肿瘤的发生发展至关重要,但 ERK1 或 ERK2 对致癌过程的具体贡献知之甚少。我们证明 ERK2 而不是 ERK1 信号对于 Ras 诱导的上皮-间充质转化 (EMT) 是必需的。此外,ERK2 的过表达而不是 ERK1 的过表达足以诱导 EMT。许多 ERK1/2 相互作用蛋白含有调节与 ERK1/2 对接的氨基酸基序,例如 DEF 或 D 基序。值得注意的是,ERK2 信号向含有 DEF 基序的靶标是诱导 EMT 所必需的,并且与迁移、侵袭和存活增加相关。重要的是,晚期反应基因产物 Fra1 通过上调 ZEB1/2 蛋白对于 Ras 和 ERK2 诱导的 EMT 是必需的。因此,ERK2 DEF 基序信号在肿瘤发生过程中的明显关键作用是 Fra1 的调节以及随后 ZEB1/2 的诱导,这表明 Ras 调节的肿瘤发生有一个潜在的治疗靶点。

相似文献

2
Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Cell Signal. 2013 Dec;25(12):2540-7. doi: 10.1016/j.cellsig.2013.08.014. Epub 2013 Aug 30.
4
Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Cell Death Differ. 2015 Feb;22(2):336-50. doi: 10.1038/cdd.2014.157. Epub 2014 Oct 10.
6
Deconstructing ERK signaling in tumorigenesis.
Mol Cell. 2010 Apr 9;38(1):3-5. doi: 10.1016/j.molcel.2010.03.012.
7
Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
Curr Biol. 2005 Jul 26;15(14):1319-24. doi: 10.1016/j.cub.2005.06.037.
9
Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Cancer Sci. 2017 May;108(5):952-960. doi: 10.1111/cas.13214. Epub 2017 May 22.
10
Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
J Biol Chem. 2009 Nov 27;284(48):33006-18. doi: 10.1074/jbc.M109.012591. Epub 2009 Oct 5.

引用本文的文献

1
Noncoding RNAs as regulators of FOSL1 in cancer.
Front Immunol. 2025 Aug 1;16:1599674. doi: 10.3389/fimmu.2025.1599674. eCollection 2025.
3
Cancer hotspot mutations rewire ERK2 specificity by selective exclusion of docking interactions.
J Biol Chem. 2025 Apr;301(4):108348. doi: 10.1016/j.jbc.2025.108348. Epub 2025 Feb 25.
4
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression.
Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):271-284. doi: 10.21873/cgp.20501.
6
Overexpression of Nogo-A changes nerve growth factor signaling dynamics in PC12 cells.
Cell Signal. 2025 Mar;127:111569. doi: 10.1016/j.cellsig.2024.111569. Epub 2024 Dec 14.
7
MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2.
Cell Mol Life Sci. 2024 Nov 23;81(1):461. doi: 10.1007/s00018-024-05505-8.
8
Methods and computational tools to study eukaryotic cell migration .
Front Cell Dev Biol. 2024 Jun 3;12:1385991. doi: 10.3389/fcell.2024.1385991. eCollection 2024.
9
Context-dependent roles for ubiquitous mitochondrial creatine kinase CKMT1 in breast cancer progression.
Cell Rep. 2024 Apr 23;43(4):114121. doi: 10.1016/j.celrep.2024.114121. Epub 2024 Apr 12.
10
Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates.
Cancers (Basel). 2023 Dec 24;16(1):95. doi: 10.3390/cancers16010095.

本文引用的文献

1
The RSK family of kinases: emerging roles in cellular signalling.
Nat Rev Mol Cell Biol. 2008 Oct;9(10):747-58. doi: 10.1038/nrm2509.
2
The epithelial-mesenchymal transition generates cells with properties of stem cells.
Cell. 2008 May 16;133(4):704-15. doi: 10.1016/j.cell.2008.03.027.
3
Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs.
J Biol Chem. 2008 Jul 11;283(28):19511-20. doi: 10.1074/jbc.M801074200. Epub 2008 May 15.
4
Lumen formation during mammary epithelial morphogenesis: insights from in vitro and in vivo models.
Cell Cycle. 2008 Jan 1;7(1):57-62. doi: 10.4161/cc.7.1.5150. Epub 2007 Oct 9.
6
Molecular definition of breast tumor heterogeneity.
Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.
9
Fra-1 a target for cancer prevention or intervention.
Gene. 2006 Sep 1;379:1-11. doi: 10.1016/j.gene.2006.05.001. Epub 2006 May 6.
10
ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1425-33. doi: 10.1016/j.bbrc.2006.05.051. Epub 2006 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验